Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals
plus dead) labeled
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Types of Multiple Myeloma | International Myeloma Foundation
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
NCI-H929细胞ATCC CRL-9068细胞H929人骨髓瘤细胞株购买价格、培养基、培养条件、细胞图片、特征等基本信息_生物风
Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Establishment of Five Human Myeloma Cell Lines
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
